States will continue to be able to leverage pandemic-era telehealth flexibilities this year following the federal governmentâs move to codify flexibilities on how health care providers can prescribe medication for treating substance use disorders.
As of Jan. 1, health care providers are able to prescribe buprenorphine, a medication used to treat opioid use disorders by reducing cravings and withdrawal symptoms, via telehealth for up to six months without requiring an in-person appointment. The rule builds upon pandemic-era flexibilities and was issued by the Drug Enforcement Administration and the Health and Human Services Department on Dec. 31, 2025.
The rule âmakes it easier for people with an opioid use disorder to access treatment,â which is âa big deal because allowing patients to access addiction treatment remotely has had a huge impact on state efforts to connect people to treatment,â said Marcelo H. FernĂĄndez-ViĂąa, who conducts law and policy analysis and research for the Substance Use Prevention and Treatment Initiative at Pew Charitable Trusts.
Between 2023 and 2024, for example, opioid overdose deaths decreased from 79,358 to 54,045 incidents following policy and programming efforts, such as distributing overdose-reversal medications, expanding the availability of drug checking and testing services and addressing cultural stigma toward substance use among policymakers and health care practitioners.
But substantial work remains to tackle Americansâ opioid use disorders, which telehealth can help further chip away at. Telehealth services, for instance, were linked to a 33% lower risk of a drug overdose among Medicare beneficiaries who received remote care during the pandemic, according to the U.S. Centers for Disease Control and Prevention.
By removing the requirement for an in-person visit before a provider can prescribe buprenorphine, for instance, leaders âmight feel more confident investing in telehealth services and building [them] out,â he said.
The new rule also discontinues recordkeeping requirements for providers offering audio-only visits, a barrier that could otherwise deter the availability of telehealth options, according to a recent Pew article authored by Fernåndez-Viùa.
Indeed, expanding the affordability and accessibility of telehealth services after other pandemic-era funding and policies have expired remains a priority for state leaders, according to a report released late last year from the Center for Connected Health Policy. A separate report also found that some telehealth patients still faced challenges accessing buprenorphine because pharmacists were skeptical of filling a telehealth-based prescription due to potential scrutiny.
Access to such care is critical for addressing the decadeslong opioid epidemic that has contributed to approximately 806,000 deaths since the 1990s. In 2017, the Health and Human Services Department declared the opioid crisis a public health emergency, which HHS Secretary Robert F. Kennedy, Jr. renewed in March 2025.